IHC analysis of lung metastases from CRC patients revealed that CCL15 expression was significantly correlated with loss of SMAD4, and that CCL15-positive metastases recruited ~1.9 times more numbers of CCR1+ cells than CCL15-negative metastases. The gene discussed is CCR1; the disease is colorectal carcinoma.